Pitfalls of HIV genotypic tropism testing after treatment interruption | Zendy

Marc Wirden | Zendy; Cathia Soulié | Zendy; S. Fourati | Zendy; M. A. Valantin | Zendy; Anne Simon | Zendy; Nadine Ktorza | Zendy; Roland Tubiana | Zendy; Manuela Bonmarchand | Zendy; Lars Schneider | Zendy; Vincent Cálvez | Zendy; Christine Katlama | Zendy; AnneGeneviève Marcelin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pitfalls of HIV genotypic tropism testing after treatment interruption

Author(s) -

Marc Wirden,

Cathia Soulié,

S. Fourati,

M. A. Valantin,

Anne Simon,

Nadine Ktorza,

Roland Tubiana,

Manuela Bonmarchand,

Lars Schneider,

Vincent Cálvez,

Christine Katlama,

AnneGeneviève Marcelin

Publication year - 2012

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dks362

Subject(s) - genotype , virology , tropism , human immunodeficiency virus (hiv) , biology , medicine , tissue tropism , genetics , virus , gene

The genotypic method is reliable enough for the determination of tropism and largely preferred in Europe. However, careful interpretation is essential when assessing HIV genotypic resistance during treatment interruption (TI) due to the possible disappearance of resistant strains. The results of HIV genotypic tropism testing in such a context remain unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research